ChemoMouthpiece, LLC

The Chemo Mouthpiece® medical device is U.S. FDA 510(k) cleared and clinically proven to reduce the incidence and severity of chemotherapy induced oral mucositis in adult patients. Ready for commercialization in Europe, we are actively seeking distribution partners to support upcoming product availability outside the United States. As the only self-contained, proactive, portable and reusable oral cryotherapy device, the Chemo Mouthpiece brings innovation and accessibility to supportive oncology care. Click Learn More to complete our distributor interest form and connect with our team. Rx Only. FDA 510(k) cleared and currently available for use in the U.S. See full Prescribing Information and Important Safety Information at www.ChemoMouthpiece.com

The Chemo Mouthpiece® medical device is FDA 510(k) cleared and clinically proven to reduce the incidence and severity of chemotherapy induced oral mucositis in adult patients. We’re now seeking distribution partners to support upcoming product availability outside the U.S. As the only self-contained, portable, and reusable oral cryotherapy device, the Chemo Mouthpiece brings innovation and accessibility to supportive oncology care. 📍Attending MEDICA 2025? Visit us in Hall 11, Stand #11-A49 | November 17–20, Düsseldorf Rx Only. See full Prescribing Information and Important Safety Information at www.ChemoMouthpiece.com.

The Chemo Mouthpiece® oral cryotherapy device is clinically proven to reduce the incidence and severity of chemotherapy induced oral mucositis. Seeking an exclusive distribution partner to introduce the Chemo Mouthpiece in Europe. Attending ESMO? 📍Visit us at Booth #4020, October 17–21 in Berlin. The Chemo Mouthpiece® medical device is FDA 510(k) cleared and currently available for use in the United States.

ChemoMouthpiece®は、化学療法誘発性口腔粘膜炎の発生と重症度を軽減することが臨床的に証明されている口腔内冷却療法装置です。ただいま独占販売パートナーを募集しています。 📍10月1日～3日、幕張メッセで開催される『メディカルジャパン東京』に出展いたします。ブース22-15にて皆さまのご来場をお待ちしております。 処方と安全性に関する詳しい情報については、ChemoMouthpiece.com をご覧ください。

Not all chemotherapy treatments affect the mouth in the same way. Some chemotherapy drugs and treatment combinations are more likely to cause oral mucositis than others. For patients receiving these treatments, mouth symptoms may appear early in treatment and can worsen during the first weeks of chemotherapy. Patients and care teams should discuss the risks of mouth sores BEFORE treatment begins. Learn more and see Important Safety Information: https://lnkd.in/g7NYdjUw

O Chemo Mouthpiece® é um dispositivo de crioterapia oral clinicamente comprovado para reduzir a ocorrência e a gravidade da mucosite oral induzida por quimioterapia. Procuramos um parceiro de distribuição de dispositivos médicos estabelecido, com experiência em oncologia, para introduzir o Chemo Mouthpiece no Brasil. O Chemo Mouthpiece possui registro como dispositivo médico Classe II no Brasil.